He is the past President of the Duval County Society of Ophthalmology, and also served as Chief of Ophthalmology at Baptist Medical Center from 2004 to 2014. Sullivan founded our expanded retina practice in an effort to provide the highest level of vitreoretinal care to patients in Northeast Florida and Southeast Georgia. While board certification is not required to practice, it does ensure that our practice meets the standards and qualifications set forth by the American Board of Ophthalmology. Shawn Agee are board certified by the America Academy of Ophthalmology and specialize in the diagnosis and treatment of vitreoretinal diseases. Research at the University of Iowa, Department of Ophthalmology, August 1992 – May 1993.Dr. Relative Contributions of the Nasal and Temporal Fields in Normal Eyes Comparison of Visual and Pupillomotor Input.

Solley W A, Sternverg P Jr.,: Retinal Phototoxicity, Int Ophthalmol Clin.

Solley W A, Vitreous Substitutes In: Vitreoretinal Surgery, Anand, R.

A Prospective Pilot Study Comparing Combined Intravitreal Ranibizumab and Half-fluence Photodynamic Therapy with Ranibizumab Monotherapy in the Treatment of Neovascular Age-related Macular Williams P D, Callanan D, Solley W, Avery R L, Pieramici D J, Aabert T., Clin Ophthalmol.A Randomized, Dose-escalation Study of Subconjunctival and Intravitreal Injections of Sirolimus in Patients with Diabetic Macular Dugel P U, Blumenkranz M S, Haller J A, Williams G A, Solley W A, Kleinman D M, Naor J,: Ophthalmology.Sub-Investigator: AGN 150998: Single-Dose Study of the Safety and Efficacy of AGN-150998 in Patients with Exudative Age-Related Macular Degeneration.Sub-Investigator: LUX 211-11: A Double-Masked, Placebo Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects with Active Non-Infectious Intermediate, Posterior or Pan-Uveitis.Sub-Investigator: AGN 206207-024: A Multi-Center, Open-Label, Randomized Study comparing the Efficacy and Safety of 700ug Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) to Ranibizumab in patients with Diabetic Macular Edema.Sub-Investigator: iDeal 2010-007-03: A Randomized, Multi-Center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injection(s) iCO-007 as Monotherapy or in Combination with Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema with Involvement of the Foveal Center.Sub-Investigator: TRA-OZAB-11-001: The Effect of Ozurdex (Dexamethasone Intravitreal Implant) 0.7mg on Efficacy of Bevacizumab Therapy for Non-Ischemic Retinal Vein Occlusion.Sub-Investigator: Regeneron VGFTe-AMD-1124: An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients with Neovascular Age-Related Macular Degeneration.

Sub-Investigator: Alcon: LHA510-2201: A Randomized, Double-Masked, Vehicle-Controlled, Proof-Of-Concept Study for Topically Delivered LHA510 as a Maintenance Therapy in Patients with Wet, Age-Related Macular Degeneration.Sub-Investigator: ACT 13480: (SANOFI): A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Effixacy and Safety of Sarilumab Administered Subcutaneously Every Two Weeks in Patients with Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU).Sub-Investigator: AGN 150998-003: A Multi-Center, Double-Masked, Randomized, 20-Week Parallel-Group, Active Controlled Study, Designed to Evaluate the Safety and Treatment Effects of Abicipar in Treatment-Naïve Patients with Neovascular AMD.Sub-Investigator: AGN 150998-004: A Multi-Center, Randomized, Double-Masked, 28-week, Parallel-Group, Active-Controlled, to Evaluate the Safety and Treatment Effects of Abicipar in Patients with Decreased Vision Due to DME Involving the Central Foveal Subfield.

North texas retina associates